Treat a supported diagnosis and reassess atypical change. A treatment list or reassuring label does not establish benignity.
Terminology and draft status
Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.
01Recognise a lesion before choosing treatment
A chalazion is usually a sterile lipogranulomatous response to retained meibomian secretion. Leakage recruits lipid-laden foam cells and multinucleated giant cells; neutrophils may occur with acute inflammation and are not an infallible infection test. 1 2
Routine tissue processing can dissolve lipid and leave empty spaces in histology. This explains the appearance, but the export provides no slide or verified pathology report; do not diagnose from a schematic description alone. 1
An acutely swollen lid may represent an inflamed chalazion, hordeolum or preseptal infection. Heat or pus alone is insufficient: check fever, tenderness, extent, vision and eye movements; reduced vision, proptosis or painful/restricted movements raise concern for orbital disease and need urgent assessment. 1 2
Inspect lashes, lid margin, conjunctiva and surrounding skin. Recurrence at the same site, lash loss, distortion or an atypical persistent lesion, particularly in an older person, warrants assessment for sebaceous carcinoma and a planned biopsy; repeated drainage without diagnosis may delay recognition. 2 3
02Treat chalazion according to findings and persistence
Warm compresses, gentle massage and lid hygiene are reasonable initial measures; multiple lesions also prompt assessment for meibomian dysfunction or rosacea. Routine antibiotics do not treat the sterile granuloma; suspected bacterial cellulitis has its own indication for systemic treatment, not simply the label “danger triangle”. 1 2 4
In a multicentre randomized trial, 149 patients received compresses alone or with tobramycin or tobramycin/dexamethasone for 4–6 weeks. Complete resolution occurred in 18% of lesions overall, with no significant between-group difference; this does not establish an added benefit of routine combination drops. Lesions and patients are different denominators; full methods and follow-up attrition were not appraised here. 4
Persistent or functionally troublesome chalazia may be treated by incision and curettage or selected intralesional triamcinolone. A single-centre randomized study of 136 patients reported resolution at 3 weeks of 84%, 87% and 46% for injection, surgery and compresses respectively. Short follow-up, telephone assessment and the abstract’s inconsistent P-value wording prevent a general equivalence or long-term safety claim. 2 5
Steroid injection can cause skin depigmentation, fat atrophy, pressure rise, penetration and visual loss. A conjunctival route may reduce skin exposure but does not eliminate risk; the export’s specific “fat embolism” explanation remains unverified rather than an established mechanism. 1 2
The source contrasts a vertical conjunctival incision with a cruciate incision and warns about glands and the nearby punctum. These are operative teaching points, not a self-contained technique: confirm anatomy and diagnosis. A chalazion is not a true epithelial cyst; “complete capsule removal” must not be read as a universal instruction for aggressive tissue stripping. 1
03Distinguish cyst contents and tissue of origin
Translucency, lid-margin location, relation to a lash and congenital onset help classify a cyst. Moll and Zeis lesions are not interchangeable with epidermoid or dermoid cysts; the table retains all seven source categories with their distinguishing features. 1
The original “sebaceous cyst” category overlaps colloquial usage: an epidermoid cyst usually contains keratin rather than sebum. A congenital superotemporal orbital dermoid near bone may extend deeper than the visible lump; plan assessment and excision according to extent, not an assumed superficial capsule. 1
| Lesion | Origin | Distinguishing feature |
|---|---|---|
| Moll / apocrine hidrocystoma | Apocrine gland | Translucent fluid cyst at lid margin. |
| Zeis cyst | Sebaceous gland of lash follicle | Opaque pale sebaceous material. |
| “Sebaceous cyst” | Original pilosebaceous/retention category; terminology overlaps | Confirm lining and contents; many so-called sebaceous cysts are keratin-containing epidermoid cysts. |
| Milia | Keratin retention | Small white lesions, sometimes grouped. |
| Epidermoid cyst | Epidermal lining without skin appendages | Congenital or post-traumatic; keratin contents. |
| Dermoid cyst | Lining includes skin appendages; choristoma | Congenital, often superotemporal orbital bone region; assess extent. |
| Eccrine hidrocystoma | Eccrine sweat gland | Usually away from the lid margin. |
04Assess epithelial and lipid lesions
Xanthelasma consists of dermal lipid-laden macrophages, often medial and bilateral. Hyperlipidaemia is not universal, but lipid assessment is relevant, particularly in younger patients; cosmetic excision, trichloroacetic acid, argon or carbon-dioxide laser require attention to ocular exposure, scarring and lid position. 1
Squamous papilloma may be pedunculated, sessile or hyperkeratotic, with an epithelial covering and fibrovascular core. Human papillomavirus can be associated but is not proved in every lesion; excision, cryotherapy or laser are selected options after diagnosis, not interchangeable treatment for an uncertain tumour. The source also names the pedunculated form fibroma pendulum and describes acanthotic, thickened squamous epithelium; HPV is the retained abbreviation. 1
Seborrhoeic keratosis, also called basal-cell papilloma or verruca senilis, often appears stuck on and contains horn cysts histologically. The name does not mean basal-cell carcinoma; shave removal, curettage or cryotherapy may suit a confirmed benign lesion, while atypical change needs diagnostic review. The described surface may be greasy, sharply demarcated, pigmented and warty. 1
Actinic keratosis reflects ultraviolet-related keratinocyte atypia, often with solar elastosis. Its relationship to squamous carcinoma matters, but not every lesion should be labelled Bowen disease; treatment and biopsy depend on clinical risk and site, rather than a universal demand for excision with a fixed margin or cryotherapy. The source describes a rough scaly lesion on an erythematous sun-exposed base and disturbed epidermal maturation; appearance alone does not replace histological assessment when needed. 1 6
05Interpret melanocytic and hair-matrix lesions
Congenital melanocytic naevi vary greatly in size and risk. The export’s 15% transformation figure for giant naevi is not verified as a general lifetime estimate or an eyelid-specific risk; a systematic-review abstract reports 91 melanomas among 7915 patients across sizes (1.15%, 95% CI 0.93–1.41), with higher risk in large/giant lesions. These are heterogeneous observed populations, not a substitute individual lifetime probability. A congenital naevus may be hairy; hair alone neither proves nor excludes malignancy. 1 7
Acquired junctional naevi tend to be flat; compound naevi include junctional and dermal components, while intradermal naevi are often raised and less pigmented. The original “zero malignant potential” statement for intradermal lesions is too absolute: examine asymmetry, border, colour, diameter and evolution, and arrange specialist assessment or planned biopsy when uncertain. Junctional nests lie at the dermoepidermal junction; intradermal cells lie in the dermis. ABCDE summarises the assessment, not a guarantee from any single feature. 1
Pilomatricoma (Malherbe tumour) is a hair-matrix lesion, often a firm deep nodule in children or young adults. Histology may show peripheral basophilic cells, central anucleate ghost or shadow cells and calcification; confirmation depends on the actual specimen, not age or hardness alone. The source calls the shadow cells eosinophilic. 1
06Separate haemangioma from vascular malformation
Infantile capillary haemangioma (“strawberry naevus”) commonly grows after birth and may involute over years; a deep component can look blue. It comprises proliferating vascular channels rather than a true cyst capsule. Observe low-risk lesions, but do not wait for visual loss when amblyopia risk, ulceration, other functional threat or permanent disfigurement makes early specialist assessment necessary. The superficial lesion may be bright red and raised, with growth particularly in early infancy. 1 8
For infantile haemangiomas requiring systemic treatment, the AAP guideline recommends propranolol, with patient-specific contraindication assessment and safety counselling. Steroids or laser have selected roles; the original list is not a menu for unsupervised treatment, and no dosing schedule is prescribed by this review. 1 8
Port-wine birthmark (naevus flammeus) is a capillary malformation that persists and may darken or thicken. Sturge–Weber risk is better considered by the developmental facial pattern, particularly forehead/upper-eyelid involvement, than by the source’s V1/V2 shorthand alone; high-risk children need baseline paediatric neurological and ophthalmic assessment with follow-up. 1 9
Sturge–Weber may involve facial skin, ipsilateral leptomeningeal vessels with seizures or hemiparesis, and glaucoma or diffuse choroidal haemangioma; not everyone has a complete triad. The 2021 consensus does not recommend routine brain screening in every asymptomatic high-risk infant, although selected imaging is appropriate; early negative MRI can be falsely reassuring and symptoms change the pathway. 1 9
07Recognise plexiform neurofibroma and plan follow-up
Plexiform neurofibroma may feel like a bag of worms and produce an S-shaped upper-lid contour with ptosis. The original calls it “pathognomonic” for neurofibromatosis type 1 (NF1); the 2021 consensus instead places one plexiform neurofibroma among the diagnostic criteria, interpreted with other findings and family history. 1 10
Document site, size, pigmentation, lash changes, photographs when appropriate and the reason for observation, biopsy or treatment. Reassess recurrence or change; the Kanski attribution and linked lecture recording remain source provenance, not proof that a particular textbook edition or speaker validated these words. 1 2 3
What are the main learning points of this lecture?
The chapters connect findings, meaning and next steps. Check diagnosis, alternatives and source limits against the individual clinical findings.
Which findings require urgent assessment?
Rapid visual deterioration, severe pain, marked inflammation, pressure rise or suspected infection/neurological disease require urgent assessment. Apply the topic-specific warning signs and clinical context.
References and access status
- 1Original exported eyelid-lesion briefing
Complete captured export and all table cells read; recording, pathology slides and Kanski edition unverified.
- 2AAO: Chalazion Management: Evidence and Questions
Actual indexed selected management, biopsy and injection-risk text read; whole article and underlying studies not all read.
- 3AAO: Diagnosis and Management of Sebaceous Carcinoma of the Eyelid
Actual indexed selected differential and biopsy text read; full oncological pathway unread.
- 4Wu et al. 2018, PMID 29338124
Complete actual NCBI XML abstract read, after a truncated Europe PMC abstract; full paper access failed and methods/supplement not appraised.
- 5Goawalla and Lee 2007, PMID 17997772
Complete actual NCBI XML abstract read; inconsistent comparative P-value wording retained as a limitation, not repaired by inference. Full paper unread.
- 6Review032 evidence transfer: S3 actinic keratosis / cutaneous SCC
Prior review032 source-access record reused explicitly; no claim of a new complete S3 guideline reading. See Issue36 transfer note.
- 7Scard et al. 2023, PMID 36149403
Complete actual NCBI XML abstract read; full selection methods, subgroup data, risk of bias and supplements unread.
- 8AAP infantile haemangioma guideline 2019
Actual indexed abstract and selected risk-stratification / propranolol action statements read; whole guideline and current local product information not appraised.
- 9Sturge–Weber consensus 2021, PMID 34153815
Actual Europe PMC abstract and indexed selected referral/imaging recommendations read; direct PMC browser blocked. Full methods, all tables and supplements unread.
- 10Legius et al. NF1 revised criteria 2021
Actual indexed selected Table1 criterion and diagnostic context read; whole consensus and genetic-testing methods unread.
Original lecture link
For patients
Many lid lumps are benign, but change or recurrence should be examined. Do not squeeze a lump or apply acids or steroid injections yourself.
A photograph or biopsy may help establish the diagnosis. Ask what is known, why treatment is proposed and what risks apply.
For a child’s vascular birthmark, early assessment can protect vision before obvious loss occurs. Keep the agreed follow-up even if the lesion looks stable.
Reduced vision, proptosis, fever with progressive lid swelling, or painful/restricted eye movements need urgent assessment. Persistent ulceration, lash loss or recurrence requires timely specialist review.